(Q51565747)

7 April 2018

review article

1 reference

title

The atherogenic significance of an elevated plasma triglyceride level. (English)

1 reference

7 April 2018

1 reference

1 reference

Ooi TC

1

1 reference

7 April 2018

Ooi DS

series ordinal

2

1 reference

7 April 2018

publication date

1 December 1998

1 reference

7 April 2018

Critical Reviews in Clinical Laboratory Sciences

published in

1 reference

7 April 2018

volume

35

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

489-516

1 reference

7 April 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Structure of human serum lipoproteins inferred from compositional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

IDL, VLDL, chylomicrons and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Atherogenesis: a postprandial phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Expression of the VLDL receptor in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Human THP-1 monocyte-macrophage membrane binding proteins: distinct receptor(s) for triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Purification of the human THP-1 monocyte-macrophage triglyceride-rich lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Lipoprotein heterogeneity and apolipoprotein B metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Plasma triglyceride and low density lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Diagnosis and classification of dyslipidemia in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Familial lipoprotein disorders in patients with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

Postprandial lipoproteins and progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408369891234255

10.1080/10408369891234255

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018